McFarland, Henry F.

From the Outpatient Clinic Neurology-Neurosurgery (Dr. Kappos), University Hospital Basel, Switzerland; Department of Neurology (Dr. Weinshenker), Mayo Clinic and Foundation, Rochester, MN; Department of Neurology (Dr. Pozzilli), University of Rome “La Sap

Citations 3

Interferon beta-1b in secondary progressive MS

Neurology | May 13, 2012 | Volume: 63 | Issue: 10 | Pages: 1779-1787

10.1212/01.wnl.0000145561.08973.4f | PMID 15557490

Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure

Neurology | May 13, 2012 | Volume: 49 | Issue: 3 | Pages: 862-869

10.1212/wnl.49.3.862 | PMID 9305355

Interferon beta results in immediate reduction of contrast‐enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI

Neurology | May 13, 2012 | Volume: 48 | Issue: 5 | Pages: 1446-1448

10.1212/wnl.48.5.1446 | PMID 9153489